volume::125mL×4
| Form::Liquid | Bacteria Detection::Negative |
| Fungi Detection::Negative | Mycoplasma Detection::Negative |
| Endotoxin Content:: | pH::7.4-7.8 |
| Components::RPMI-1640 [PM150110]+10% Nutrient+100 U/mL recombinant IL-2+1.0 μg/mL Supplement1+1% Supplement2 | Green Features::Sustainable packaging |
| Valid Period::6 months | Storage Condition::This product can be stored at 2-8℃ for 6 months with shading light. |
| Matters Need Attention::1. This product is for research use only. 2. This product is sterilized by 0.1 μm filtration. 3. It is necessary to pay attention to the aseptic operation and avoid the contamination during the culture. 4. It is not suitable for long time storage at room temperature. 5. This product is a ready-to-use medium. If there is no special need, don't add serum, penicillin and streptomycin. It can be used directly. | System Certification::GMP Production and Quality System The company complies with cGMP requirements, holds the NMPA medical device registration certificate, and is certified under ISO 13485 and ISO 9001 standards. Among its products, the company's CTLL-2 Cell Complete Medium complies with ISO 9001. |
| biogegep7 | biogegep17 |
| biogegep8 | biogegep18 |
| biogegep9 | biogegep19 |
| biogegep10 | biogegep20 |
Title: BBB-penetrating biomimetic nanoparticles orchestrate STING activation and metabolic immunomodulation for potent glioma immunotherapy
Journal: Nano Today (2026)
IF: 10.7
DOI: 10.1016/j.nantod.2026.103061
Article URL: https://www.sciencedirect.com/science/article/pii/S1748013226000885
Product Cited: CTLL-2 Cell Complete Medium, CTLL-2 Cells Line
Title: Cholesterol Metabolism Regulated Nanoliposome Ameliorates Chemo/Photothermal Therapy Reversing CD8+ T Cell Exhaustion
Journal: Exploration (2025)
IF: 22.5
DOI: 10.1002/EXP.20240123
Article URL: https://onlinelibrary.wiley.com/doi/abs/10.1002/EXP.20240123
Product Cited: DC2.4 Cell Complete Medium, CTLL-2 Cells Line, DC2.4 Cells Line, CTLL-2 Cell Complete Medium
Title: Resveratrol-loaded macrophage exosomes alleviate multiple sclerosis through targeting microglia
Journal: JOURNAL OF CONTROLLED RELEASE (2022)
IF: 11.5
DOI: 10.1016/j.jconrel.2022.12.026
Article URL: https://www.sciencedirect.com/science/article/pii/S0168365922008409
Product Cited: RAW 264.7 Cells Line, DC2.4 Cells Line, CTLL-2 Cells Line, CTLL-2 Cells Complete Medium, BV2 Cells Line, U-87 MG Cells Line